Blue Path Capital Management, LLC Gilead Sciences, Inc. Transaction History
Blue Path Capital Management, LLC
- $133 Billion
- Q1 2024
A detailed history of Blue Path Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Blue Path Capital Management, LLC holds 7,340 shares of GILD stock, worth $570,538. This represents 0.41% of its overall portfolio holdings.
Number of Shares
7,340
Previous 7,120
3.09%
Holding current value
$570,538
Previous $602 Million
10.64%
% of portfolio
0.41%
Previous 0.51%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
1,886Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$9.52 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.92 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$6.57 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.76 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.49 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $97.4B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...